FDA orphan drug designation: treatment of myelofibrosis
All entries for: Chengdu Zenitar Biomedical Technology Co.
December 18, 2025
Chengdu Zenitar Biomedical Technology Co.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of myelofibrosis